MGC Pharmaceuticals Ltd shares have doubled in value in a month

The MGC Pharmaceuticals Ltd (ASX:MXC) share price is up 7% today, taking its one-month gain to over 100%. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Although the market has sunk lower today, that hasn't stopped the MGC Pharmaceuticals Ltd (ASX: MXC) share price from racing higher.

At lunch the cosmetic cannabis company's shares are up 7% to 7.9 cents, stretching their one-month return to over 100%.

Why are its shares racing higher today?

This morning MGC Pharmaceuticals' 51%-owned subsidiary MGC Derma announced the receipt of its formal purchase order from South Korea-based Varm Cosmo for cannabidiol (CBD) cosmetic products.

This is the first binding sales agreement to be executed with the cosmetics company and is for a minimum contracted volume of $8 million of product. Two more agreements are expected to be closed in the coming weeks, with a further two agreements being finalised.

These will ultimately bring the total value of the agreements to $40 million.

What's next?

In my opinion it really does all depend on the success of these products in the South Korea market.

The South Korean cosmetics market is not just lucrative, but also very influential. If the products, which will be white-labelled and sold as part of Varm Cosm's range, are a success, then there's every chance that they could end up being sold all over the world and even in Australian Pharmaceutical Industries Ltd (ASX: API) operated Priceline stores.

This could put MGC Pharmaceutical in a position to deliver explosive sales growth over the next few years.

However, as promising as this is, I would suggest investors wait to see how well the products sell before making an investment.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »